[Uncommon neonatal case of hypoglycemia: ACTH resistance syndrome]

O Delmas1, C Marrec1, E Caietta2

  • 1Service de pédiatrie multidisciplinaire, pôle médical et chirurgical de pédiatrie, Aix-Marseille université, hôpital de la Timone-Enfants, Assistance publique des hôpitaux de Marseille, 13005 Marseille, France.

Insights

Early diagnosis of neonatal hypoglycemia is crucial. This case highlights isolated glucocorticoid deficiency, emphasizing the need for etiological diagnosis to prevent severe neurological injury in infants.

Area of Science:

  • Endocrinology
  • Neonatology
  • Genetics

Background:

  • Neonatal hypoglycemia monitoring is standard for high-risk newborns, but etiological diagnosis is often overlooked.
  • Prompt management of neonatal hypoglycemia is vital to prevent long-term neurodevelopmental deficits.
  • Identifying the underlying cause of persistent or unexplained hypoglycemia is essential.

Observation:

  • A 10-month-old infant presented with recurrent infections, neonatal hypoglycemia, and jaundice.
  • The patient experienced seizures, shock, hypoglycemia, hyponatremia, hyperpigmentation, and coma at 10 months.
  • Diagnostic workup revealed hypocortisolemia, elevated ACTH, and brain injury consistent with hypoxic-ischemic and hypoglycemic encephalopathy.

Findings:

  • The infant was diagnosed with isolated glucocorticoid deficiency.
  • Molecular analysis identified novel MC2R gene mutations (p.Asp107Asn and p.Pro281GlnfsX9).
  • Hormone replacement therapy prevented further adrenal crises during 12-month follow-up.

Implications:

  • This case underscores the importance of thorough etiological investigation for neonatal hypoglycemia.
  • Early diagnosis and treatment of familial glucocorticoid deficiency can prevent severe neurological complications.
  • Genetic testing for MC2R mutations should be considered in unexplained neonatal hypoglycemia cases.

Related Concept Videos

Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features...
1
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.4K
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the...
13
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
4.2K
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
3
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose...
2